CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials
In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC
Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels
“Withheld” News Release On QRA Policies Released
CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch
DRCCA Board Oks Noncompetitive Contract Concepts
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy









